Registration Options

Activity Dates: 05/10/2021 - 04/21/2024

Members can access this product for only $35. Log in or Join now!

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

Motor fluctuations are important complications of long-term carbidopa/levodopa therapy and advanced Parkinson Disease (PD). These complications, especially delayed-on, carbidopa/levodopa dose-failure, random on-off periods and dyskinesia (e.g. peak-dose) in advanced stages are difficult to manage and have a significant impact on quality of life. In recent years, new formulations and methods of delivery of carbidopa/levodopa, apomorphine and amantadine or new agents belonging to selective adenosine A2A receptor antagonists and MAO-B and COMT inhibitors have been developed to aid in the management of these motor complications. These newly-approved medications and additional agents currently in phase III clinical trials should or will be part of the clinical “toolbox” for management of motor symptoms and complications in advanced PD. Clinicians managing PD should be familiar with these new pharmacologic modalities and should know when and how to use them when designing the plan of care for their patients. This program aims to provide information regarding management of motor complications in PD with emphasis on newly-approved medications/formulations and agents in Phase III clinical trials. It is crucial that clinicians be knowledgeable about new strategies to promote optimal quality of life for those suffering from disabling motor complications in order to achieve high-quality PD care.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Describe motor fluctuations in Parkinson disease (PD), and understand their impact on quality of life.
  2. Discuss available non-pharmacologic and pharmacologic treatment strategies for management of motor fluctuations.
  3. Understand the role of newly approved pharmacological treatment options and agents in phase III trials in the management of motor fluctuations.
  4. Given an individual clinical scenario, develop a pharmacotherapy plan and patient education strategies for an individual with PD motor fluctuations.

Continuing Education Credit and Disclosures

Activity Dates: 05/10/2021 - 04/21/2024
ACPE Contact Hours: 1
ACPE Number: 0284-0000-21-011-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.